Share
Journal Information
Issue
Vol. 29. Issue S1.Update on tuberculosis
Pages 1-62 (March 2011)
Introduction
Fernando Alcaide, Joan A. Caylà
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:1
Full text access
Open Article
Present epidemiology of tuberculosis. Prevention and control programs
Àngels Orcau, Joan A. Caylà, José A. Martínez
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:2-7
Full text access
Open Article
Innovations in the molecular epidemiology of tuberculosis
Darío García de Viedma, Igor Mokrousov, Nalin Rastogi
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:8-13
Full text access
Open Article
The secret trumps, impelling the pathogenicity of tubercle bacilli
Pere-Joan Cardona, Juraj Ivanyi
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:14-9
Full text access
Open Article
Tuberculosis in special populations
Miguel Santín Cerezales, Enrique Navas Elorza
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:20-5
Full text access
Open Article
Diagnosis of tuberculosis infection using interferon-γ-based assays
Miguel Santín Cerezales, José Domínguez Benítez
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:26-33
Full text access
Open Article
Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance
Fernando Alcaide, Pere Coll
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:34-40
Full text access
Open Article
Present-day treatment of tuberculosis and latent tuberculosis infection
Inés Pérez-Camacho, Antonio Rivero-Juárez, José María Kindelán
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:41-6
Full text access
Open Article
New drugs for tuberculosis treatment
Francesca Sánchez, José L. López Colomés, Elsa Villarino, Jacques Grosset
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:47-56
Full text access
Open Article
New tuberculosis vaccines
Carlos Martín Montañés, Brigitte Gicquel
Enferm Infecc Microbiol Clin. 2011;29 Supl 1:57-62
Full text access
Open Article
Publish in
Enfermedades Infecciosas y Microbiología Clínica
La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:
SOCIOS PROTECTORES
-
- Pfizer GEP, S.L.U.
- Shionogi, S.L.U.
- AbbVie Spain, S.L.U.
- Gilead Sciences, S.L.U.
- Vircell Spain, S.L.U.
- Roche Diagnostics, S.L.U.
- ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
- Qiagen Iberia S.L.
- Laboratorios ViiV Healthcare, S.L.
SOCIOS PATROCINADORES
- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.
Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals